75
Views
53
CrossRef citations to date
0
Altmetric
Original article

Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction

, , , , , , & show all
Pages 497-504 | Received 25 Mar 2003, Accepted 06 Oct 2003, Published online: 08 Jul 2009

REFERENCES

  • Moolenaar WH. Lysophosphatidic acid, a multi-functional phospholipid messenger. J Biol Chem 1995; 270: 12949–52.
  • Moolenaar WH. LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol 1994; 4: 213–9.
  • Xu Y, Ouk Kim S, Liao D, Katz S, Pelech SL. Stimulation of 90- and 70-kDa ribosomal protein S6 kinases by arginine vasopressin and lysopho-sphatidic acid in rat cardiomyocytes. Biochem Pharmacol 2000; 59: 1163–71.
  • Eichholtz T. The bioactive phospholipid lysopho-sphatidic acid is released from activated platelets. Biochem J 1993; 291: 677–80.
  • Goetzl EJ. Distinctive expression and functions of the type4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 1999; 59: 5370 — 5.
  • Sasagawa T. Abnormal serum lysophospholipids in multiple myeloma patients. Lipids 1999; 34: 17–21.
  • He LJ, Han BM, Chen X, Li HW, Shen LH. Study on the role of lysophophatidic acid and its receptor in heart remodeling. China Med Trib 2001; 27: 7.
  • Chen JH, Zou F, Wang ND, Xie SW, Zhang X. Production and application of LPA polyclonal antibody. Bioorg Med Chem Lett 2000; 10: 1691.
  • Tigyi G, Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 1992; 267: 21360— 7.
  • Panetti TS, Magnusson MK, Peyruchaud O, Zhang Q, Cooke ME, Sakai T. Modulation of cell interactions with extracellular matrix by lysop-hosphatidic acid and sphingosine 1-phosphate. Prostaglandins 2001; 64: 93–106.
  • Ediger TL, Toews ML. Dual effects of lysopho-sphatidic acid on human airway smooth muscle cell proliferation and survival. Biochim Biophys Acta 2001; 1531: 59–67.
  • Xu Y, Shen ZZ, Wiper DW, Wu MZ, Morton RE, Casey G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280: 719–23.
  • Stith BJ, Hall J, Ayres P, Waggoner L, Moore JD, Shaw WA. Quantification of major classes of Xenopus phospholipids by high performance liquid chromatography with evaporative light scattering detection. J Lipid Res 2000; 41: 1448–54.
  • Xiao YJ, Chen YH, Kennedy AW, Belinson J, Xu Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ioniza-tion mass spectrometry (ESI-MS) analyses. Ann N Y Acad Sci 2000; 905: 243–59.
  • Saulnier-Blache JS, Girard A, Simon MF, Lafontan M, Valet P. A simple and highly sensitive radioenzymatic assay for lysophosphati-dic acid quantification. J Lipid Res 2000; 41: 1947 — 51.
  • Okusa MD, Ye H, Huang L, Sigismund L, Macdonald T, Lynch KR. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003; 285: F565–74.
  • Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2001; 33: 1713–7.
  • De Vries B, Matthijsen RA, Van Bijnen AA, Wolfs TG, Buurman WA. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activa-tion. Am J Pathol 2003; 163: 47–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.